Oracle Bone Script, a writing system engraved in the cultural DNA of ancient Chinese civilization, emerged in the late Shang Dynasty and used tortoise shells and animal bones as its medium to record the sparks of wisdom of early human civilization. As one of the earliest mature forms of writing in China, it has spanned more than three thousand years, remaining radiant despite the passage of time. It is not only a wellspring of the development of Chinese characters, but also a highly recognizable "code of Eastern civilization" in world history, marking an irreplaceable milestone in the study of linguistic evolution, writing as an art form, and the social landscape of ancient China and beyond.

When "Oracle" becomes the name of a modern language service enterprise, the profound legacy of this ancient civilization resonates deeply with the mission of contemporary communication. Rooted in reverence for this historical heritage and driven by a vision of the boundless possibilities of future cross-language communication, Glyph Translation builds a modern bridge connecting diverse languages and cultures under the spiritual inspiration of this ancient script.

We move beyond the superficial positioning of "single-language conversion" and focus on providing full-spectrum translation solutions covering translation, interpretation, Multimedia Localization, and software internationalization. From the precise delivery of business documents to the localization of cultural content, from smooth real-time interpreting to the cross-border compatibility of software systems, every service is designed to break down language barriers and enable ideas, cultures, and values from different regions to connect and thrive through meaningful exchange.

More importantly, we always regard "inheriting and promoting Chinese cultural heritage" as our corporate spiritual responsibility. We not only help Chinese culture reach the world through professional services but also proactively convey the profound heritage of Chinese civilization carried by Oracle Bone Script in cross-cultural communication. This allows this ancient and brilliant cultural light to be revitalized on the globalized world stage, serving as a vivid footnote for mutual understanding and appreciation among different civilizations.

In the current era of profound globalization, Oracle Translation has long surpassed its mere role as a "commercial translation service provider." We steadfastly position ourselves as "advocates of cultural exchange," firmly believing that professional language services are not only a medium for information transmission but also a crucial bridge that breaks cultural barriers and promotes mutual appreciation among civilizations. We are committed to enabling cognitive resonance among different regions through understanding and respect.

As a leading AI-powered language service provider, we are committed to eliminating barriers to cross-language communication and have developed deep expertise in customized localization and language solutions for the life sciences sector. With more than two decades of industry experience, the company has ranked among the world’s top 100 professional translation agencies. Its core brand, "Medical Translation Valley," has become a benchmark in the life sciences field, providing one-stop "multilingual translation + end-to-end localization" services for specialized sectors such as medicine, pharmacy, biology, and medical devices, enabling professional value to cross borders without barriers.

"Refining medicine with excellence, ensuring smooth translation pathways" is the Service Philosophy we have always upheld: using "efficiency" to shorten cross-regional collaboration cycles, "excellence" to safeguard the precision of professional content, "professionalism" to meet the rigorous standards of the life sciences sector, and "integrity" to build a solid foundation of long-term trust with our clients. We understand that language services in the medical and pharmaceutical fields are not only essential to the global expansion of enterprises, but also carry the social responsibility of enabling cross-cultural medical knowledge sharing and fostering a global consensus on health. It is this conviction that drives us to deliver high-quality multilingual services while always approaching our work from the perspective of cultural exchange—helping medical and pharmaceutical companies connect with international markets and cross-cultural medical communities, so they can convey not only professional value, but also cultural warmth, throughout their global journey.

Since its inception, Glyph Translation has established a core development strategy of "independent R&D as the foundation, continuous innovation as the soul." We have remained deeply committed to the language services sector, building differentiated competitive advantages through technological breakthroughs. To date, the company has obtained more than 80 computer software copyright registration certificates, reinforcing its industry leadership with strong technical capabilities.

As one of the few benchmark enterprises in the language services sector to have simultaneously obtained four authoritative ISO certifications, we have built a comprehensive compliance management system:
ISO 17100 Translation Service System Certification (the core standard in the translation services sector)
ISO 9001 Quality Management System Certification (standardized control across the entire process)
ISO 13485 Medical Device Quality Management System Certification (specialized compliance for a vertical sector)
ISO 27001 Information Security Management System Certification (comprehensive data security protection)

In addition, the company has maintained honored membership status for many consecutive years in the Translators Association of China (TAC), the American Translators Association (ATA), the Japan Translation Federation (JTF), and the Globalization and Localization Association (GALA). Deeply integrated into the global language services ecosystem, we demonstrate our industry influence through internationally recognized professional credentials.

In building our Core Capabilities, we have assembled a senior language service team with deep expertise in the life sciences sector. Our team combines extensive industry experience with strong professional competence, delivering the dual strengths of linguistic excellence and domain knowledge. By leveraging the deep integration of cloud-based collaboration systems and AI engines, we have developed an innovative human-machine collaboration model that enables ultra-fast delivery and rigorous quality control for large-scale projects, redefining service efficiency and quality standards in the industry.

Based on the above Core Advantages, we have built a full-spectrum service matrix for the life sciences sector: Core Service: Precise and efficient medical translation Extended Services: End-to-end consulting on global regulatory registration for pharmaceuticals and medical devices Value-Added Services: Native-level writing, editing, and publishing support for publication in international SCI journals and for patent applications

Through integrated service solutions, we help clients seamlessly connect academic frontiers with market applications, accelerate the transformation of research results and global expansion, and provide strong language support for innovation in the life sciences sector.

With deeper global collaboration in pharmaceutical R&D, the accelerated international expansion of medical devices, and surging demand for the international publication of scientific research achievements, language services in the life sciences sector have evolved far beyond traditional "small-scale, single-language" literature translation and report conversion. They are now moving toward large-scale multinational project collaboration (such as multi-center clinical trial documentation), multilingual compliance adaptation (such as regulatory submission materials for different countries), integrated service model innovation (such as the integration of translation, regulatory consulting, and localization), and coverage of highly complex international scenarios (such as international academic conferences and overseas factory training). This transformation requires service providers not only to master terminology in specialized fields such as medicine, pharmacy, and device engineering, but also to be highly familiar with the requirements of global regulatory authorities such as the FDA, EMA, and NMPA, in order to support the global expansion of life sciences enterprises and cross-border collaboration among research institutions.

Drawing on the professional expertise of its "Medical Translation Valley" brand, Glyph Translation has built a high-quality client portfolio in the life sciences sector spanning multinational pharmaceutical companies, innovative biotechnology companies, high-end medical device enterprises, and leading research institutions. Our clients are all benchmark organizations in their respective fields:

1. Multinational Pharmaceutical Companies: AstraZeneca, MSD, and Bayer (supporting global registration submissions for new drugs by providing multilingual clinical trial protocol translation, package insert translation, and localization of regulatory documents to meet compliance requirements in Europe, the United States, the Asia-Pacific region, and other markets);
2. High-End Medical Device Manufacturers: Siemens Healthineers, Mindray, and Carl Zeiss (delivering multilingual translation of technical documentation, localization of user manuals, and adaptation of overseas training materials for medical imaging equipment, surgical instruments, and in vitro diagnostic products, while balancing technical precision with clinical use scenarios);
3. Innovative Biotechnology Companies: Innovent Biologics, BGI, and Sinocelltech (providing experimental report translation, patent document writing support, and Interpretation Services for international collaboration during the R&D of gene and cell therapies);
4. Leading Research Institutions: the Chinese Academy of Medical Sciences, the Translational Medicine Center of Peking Union Medical College, and the Shanghai Jiao Tong University School of Medicine (supporting international collaborative research, academic paper editing, such as for SCI journal publication, and real-time Interpretation Services for international scientific collaboration conferences).

The multilingual language services that Glyph Translation provides to the above life sciences clients are consistently guided by the philosophy of "refining medicine with excellence, ensuring smooth translation pathways." With service standards defined by "zero terminology deviation, zero compliance omission, and zero delivery delay," we closely align with the sector’s core demands for high precision, high compliance, and high timeliness. As a result, we have earned broad recognition from the regulatory teams of multinational pharmaceutical companies, the overseas market departments of device manufacturers, and research groups at scientific institutions, becoming an indispensable language service partner in the globalization journey of many life sciences organizations.

Global Strategic Footprint: Based in China, Positioned at Key Global Industry Hubs

Glyph Translation adopts a layout logic of "deepening local roots and serving the globe," dividing its global operational system into a "China Core Zone" and "Overseas Key Zones." Each branch precisely aligns with the industrial needs of the life sciences sector, forming a service network of "local response and global synergy":
China Region: Headquarters coordination + nationwide coverage Shenzhen, China (Global Headquarters), Beijing, China, Shanghai, China, Guangzhou, China Overseas Key Regions: Anchoring high-value life sciences markets London, UK, Frankfurt, Germany, Bangalore, India, Toronto, Canada, Tokyo, Japan

Professional Team and Service Capabilities: A Global Footprint Supporting Life Sciences Service Delivery

Relying on the 9 core nodes mentioned above (4 cities in China + 5 overseas cities), Glyph Translation has built a global team of over 500 people, with the dedicated life sciences team accounting for more than 75%. Each branch is equipped with a dual-role configuration of "local language experts + life sciences specialists":
Domestic branch teams are familiar with China's NMPA regulations and can quickly respond to the needs of enterprises seeking multilingual registration support for global expansion;
Overseas branch teams have a deep understanding of local regulatory standards and can provide precise localization services for foreign enterprises entering China.
Currently, the company can provide dedicated life sciences services in over 65 languages for the 120+ associated markets covered by the aforementioned Countries and Regions, with localized adaptation that truly enables "one local need, a globally coordinated response."